The opportunity for the export situation of epoxy is extremely serious remains

For a long time, propylene-propylene has been one of the main varieties of chemical raw materials exports in China. In recent years, China's exports of cyclopropyl-saccharine have fallen sharply, attracting attention.prices rose in
china's exports of cyclopropyl saccharine for several years in a row showed a downward trend (see chart). In the case of a sharp decline in export volume, export prices are very strong, showing a steady upward trend. In 2013, the average export price of China's epoxy star was $28.2 per kilogram. In 2014, it was $30.4 per kilogram, up 7.8 percent from a year earlier. In 2015, it was $30.7 per kilogram, up 1% year-on-year. It was $32 per kilogram in 2016, up 4.2 percent from a year earlier.
Zhejiang Jingxin Pharmaceuticals, Zhejiang Guobang Pharmaceuticals, Zhejiang Langhua Pharmaceuticals, Zhejiang Huayi Pharmaceuticals, Zhejiang Pharmaceutical Xinchang Pharmaceutical Factory and other enterprises are china's main production and export enterprises of propylene-saccharin raw materials. Zhejiang Jingxin Pharmaceutical Co., D.C., has obtained a COS certificate, but also passed the EDQM on-site inspection, but also obtained the French GMP certificate. The annual production capacity, output and export volume of these enterprises account for 70% to 80% of the country's total.number of approvals plummeted
in the 1990s, due to the market conditions of the then ring propylene sand star is optimistic, a total of hundreds of enterprises in the country on the horse ring propylene sand star apidstock. In recent years, the market integration efforts have been further intensified, many enterprises have withdrawn from the ranks of production. According to the relevant data on the website of the State Food and Drug Administration, as of July 15 this year, there were 415 approval numbers for the production of propylene saccharin in China, of which 387 were approved for the production of preparations and 28 were approved for the production of RAW drugs, involving 21 enterprises. Among the raw materials, there are 12 approval numbers for the production of lactic acid cycloproxacin, the production enterprises are: Sichuan Xin kaiyuan Pharmaceuticals, Henan Kangda Pharmaceuticals, Shangyujing New Pharmaceuticals, Tianjin Pharmaceutical Research Institute Pharmaceuticals, Shandong Xinhua Pharmaceuticals, Shanxi Boda Pharmaceuticals, Shanxi Yunpeng Pharmaceuticals, Zhejiang Pharmaceutical Xinchang Pharmaceuticals, Yueyang Tonglian Pharmaceuticals, Guangzhou Baiyunshan Pharmaceuticals, Zhejiang Guobang Pharmaceuticals, Shanghai.
Cloric acid cyclopropylsacin production approval number 16, production enterprises are: Yueyang Tonglian Pharmaceuticals, Shanxi Boda Pharmaceuticals, Henan Konda Pharmaceuticals, Guangzhou Baiyunshan Chemical Pharmaceutical Factory, Jiangxi Land Pharmaceuticals, Zhejiang Langhua Pharmaceuticals, Zhejiang Pharmaceuticals Xinchang Pharmaceutical Factory, Zhejiang Guobang Pharmaceuticals, Zhejiang Huayi Pharmaceuticals, Zhejiang Haizheng Pharmaceuticals, Chongqing Southwest Synthetic Pharmaceuticals, Shangyujing New Pharmaceuticals, Tianfang Pharmaceuticals, Shanxi Yunpeng Pharmaceuticals, Taicang Pharmaceuticals, Shandong Health Pharmaceuticals.
At present, the production of propylene propylene saccharin API in China is mainly concentrated in the eastern coastal provinces, in 28 API production approvals of 16 enterprises in the eastern coastal provinces and cities, including Zhejiang Province, Zhejiang Province has 9 propylene saccharin API approval number, accounting for about one-third of the total number of the country. In recent years, China's economically developed eastern provinces are actively changing the development model, and constantly increase environmental protection control efforts, serious environmental pollution products and projects to adopt zero tolerance, some production enterprises have to stop production, production reduction.environmental protection pressure fear of losing the market
according to analysis, the future of the ring propylene sand star market is still optimistic. Propylene acetate is the third generation of fluoroquinoquinosterone anti-infector drugs, with strong antibacterial ability, a broad antibacterial spectrum, small side effects and so on, better than other similar drugs and cephalosporine, amino glycoside and other anti-infector drugs. Later, a number of new anti-infector drugs, including fluoroquinone, large ring endoesters, cephalosporine drugs, etc., have caused a greater impact on the older generation of antimicrobial drugs such as cyclopropyl sarcoidosis, so that its market share has declined.
in recent years, it has been found that some of the new anti-infective drugs have had greater toxic side effects, that some drugs are not as effective after clinical application as clinical trial reports suggest, and that some new drugs are expensive to market. And then look at cyclopropyl sassin, which has been used for more than 30 years of old antimicrobial drugs, its efficacy is accurate, antibacterial spectrum, a wide variety of preparations, small side effects, doctors and patients are more familiar with it, in many countries and regions are listed as basic drugs. In particular, cyclopropylsacine has a unique effect on some germs, such as its significant antibacterial effect on anthrax bacteria, which is unmatched by other antimicrobial drugs.
addition, there are many varieties of preparations, clinical selectivity and wide application. In our country, the variety of cyclopropyl sassing preparations have tablets, capsules, injections, creams, gels, eye drops, ointments, vaginal foam tablets, supposits and so on. And the price of propylene sand star is very low, cost-effective, especially suitable for the vast number of developing countries.
recent years, the main destination countries of China's exports of propylene propylene sarin apia are these populous developing countries, concentrated in Southeast Asia, South Asia, South America, Africa and other places. According to relevant statistics, the top 10 countries in China in 2014 were Pakistan (10.57 per cent), Bangladesh (9.47 per cent), Indonesia (8.58 per cent) and India (7.69 per cent). Spain (4.26 per cent), Peru (4.19 per cent), Slovenia (4.19 per cent), Belgium (4.12 per cent), Viet Nam (3.91 per cent), Mexico (3.50 per cent), etc. Seven of these 10 countries are developing countries, accounting for 48.3 per cent of total exports. Spain used to be the second largest destination country for our exports, accounting for about 20 per cent of total exports, and has slipped to fifth place, accounting for less than 5 per cent.
expected that the future demand in the global market is still relatively strong, after the market still has some room for development. China's enterprises due to environmental protection management and other aspects of the impact of limited production, production decline, enterprise production of raw materials can only maintain the enterprise and the domestic market production of propylene sassing preparations, no more products for export. If we can not effectively solve the environmental protection management and other issues, the future of China's cyclopropyl saccharine raw materials will gradually lose the international market share. (Medical Economics)